medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2012, Number 1

<< Back Next >>

Acta Med 2012; 10 (1)

Analgesic effect hyperbaric oxygen (HBO)

Korrodi AAIII, Sánchez REC, Fung AJA, Abreu RÓA, León MG, Gamboa BME, Gudiño CY

Language: Spanish
References: 30
Page: 9-13
PDF size: 250.15 Kb.


ABSTRACT

Introduction: Pain is a complex process, produced by diverse origin stimuli. It is classified based upon its etiology as nociceptive, neuropathic and psychogenic, and by duration as acute or chronic. With hyperbaric oxygen (HBO) therapy is possible to improve pain symptoms, by correcting most of the mechanisms responsible of its genesis. Material and methods: 60 patients were evaluated (40 males and 20 females) aged between 7 to 78 years old, during a 10 month period. The evaluation was made using Visual Analog Pain Scale (VAPS), before and after treatment with HBO. The pressure during HBO therapy was between 1.5 and 2.0 absolute atmospheres, in an effective treatment time of 60 to 90 minutes. Results: According VAPS previous HBO treatment 60% (36) of patients rated pain 7 to10, 20% (12) of patients 5 to 7, 15% (9) of patients 5 and 5% (3) below 5. After HBO treatment a significant (p ‹ 0.001) reduction of pain was observed. According VAPS 75% (45) of patients rated 0 to 1, 20% (12) of patients rated 2 and 5% (3) reported no improvement in pain perception. Conclusions: HBO therapy has been shown to induce analgesia, improving therefore significantly the quality of life of patients.


REFERENCES

  1. Bistre S, Araujo M. Dolor: síntoma, síndrome y padecimiento. Azerta Comunicación Creativa 2003: 17-28.

  2. International Association for Study of Pain (IASP). Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2a ed., Merzkey, H. & Bogduk, N., Seanle, WA, USA, 2002.

  3. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429(1-3): 23-37.

  4. Inoue K, koizumi S, Tsuda M, Shigemoto-Mogami Y. Signaling of ATP receptors in glia-neuron interaction and pain. Life Sci 2003; 74(2-3): 189-197.

  5. Inoue K, Tsuda M, Koizumi S. ATP-and adenosine-mediated signaling in central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4: J Pharmacol Sci 2004; 94(2): 112-114.

  6. Finsterer J. Mitochondrial neuropathy. Clin Neurol Neurosurg 2005; 107(3): 181-186.

  7. Chiechio S, Copan A, De Petris L, Morales ME, Nicoletti F, Gereau RW. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-Kappa pathway in primary dorsal root ganglia neurons: A possible mechanism for the analgesic effect of L-acetylcarnitine. Mol Pain 2006; 2: 20.

  8. Milligan ED, O’Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema RP, Holguin A, Martin D, Maier SF, Watkins LR. Intrathecal HIV-1 envelope glycoprotein gp 120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines: J Neurosci 2001; 21(8): 2808-2819.

  9. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 2005; 22(8): 1977-1986.

  10. Zhao Z, Chen SR, Eisenach JC, Busija DW, Pan HL. Spinal cyclooxygenase-2 is involved in development of allodynia after nervier injury in rats. Neuroscience 2000; 97(4): 743-748.

  11. Schafers M, Svenssons CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003; 23(7): 2517-2521.

  12. Peng XM, Zhou ZG, Glorioso JC, Fink DJ, Mata M. Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol 2006; 59(5): 843-851.

  13. O’Rielly DD, Loomis CW. Increased expression of cyclooxigenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology 2006; 104(2): 328-337.

  14. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005; 115(1-2): 71-83.

  15. Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA. Acute peripheral inflammation induces moderate glial activation and spinal IL-beta expression that correlates with pain behavior and the rat. Brain Res 1999; 829(1-2): 209-221.

  16. Xie W, Liu X, Xuan H, Luo S, Zhao X, Zhou Z, Xu J. Effect of betamethasone on neuropathic pain and cerebral expression of NF-kappaB and cytokines. Neurosci Left 2006; 393(2-3): 255-259.

  17. Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM. CSM 2007, spinal cord injury thematic poster presentations: Remote microglial activation and the production of proinflamatory cytokines predicts the development of neuropathic pain after spinal cord injury. J Neurol Phys Ther 2006; 30(4): 201-208.

  18. Sakaue G, Shimaoka M, Fukuoka T, Hiroi T, Inoue T, Hashimoto N et al. NF-kappa B decoy suppresses cytokines expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 2001; 12(10): 2079-2084.

  19. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ. Spinal NF-kB activation induces COX-2 up regulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004; 19(12): 3375-3381.

  20. Chen SR, Pan HL. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured Rats. J Pharmacol Exp Ther 2005; 312(1): 120-126.

  21. Milligan ED, Twining C, Chacur M, Biedenkapp J, O’Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR. J Neurosci 2003; 23(3): 1026-1040.

  22. Colburn RW, Rickman AJ, De Leo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 1999; 157(2): 289-304.

  23. Wada A. Roles of voltage-dependent sodium channels in neuronal development, pain, and neurodegeneration. J Pharmacol Sci 2006; 102(3): 253-268.

  24. Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004; 24(20): 4832-4839.

  25. Todorovic SM, Jevtovic-Todorovic V. The role of T-type calcium channels in peripheral and central pain processing. CNS Neurol Disord Drug Targets. 2006; 5(6): 639-653.

  26. Feldmeir J. HBO Committe Report. Ed. Undersea and Hyperbaric Medical Society, 2003.

  27. Sánchez EC. Hyperbaric oxigenation (HBO2) in peripherial nerve repair and regeneration. J Neuro Rev 2007.

  28. Yildiz S, Uzun G, Kiralp MZ. Hyperbaric oxigen therapy in chronic pain management. Current Pain Headache Rep 2006; 10(2): 95-100.

  29. Marianne JK et al. Analgesic effect of hyperbaric oxygen for pain caused by cancer treatment. Journal of Palliative Care 1999; 15(2): 53-55.

  30. Eguiluz-Ordoñez R, Sánchez EC, Venegas A, Figueroa-Granados V, Hernandez-Pando R. Effects of hyperbaric oxygen on peripheral nerves. Plast Reconst Surg 2006; 118: 350-357.




2020     |     www.medigraphic.com